• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算对接分析预测纤溶酶与底物和抑制剂的亚位相互作用。

Predicting subsite interactions of plasmin with substrates and inhibitors through computational docking analysis.

机构信息

Computer-Aided Molecular Modeling Research Center, Kansai (CAMM-Kansai), Kobe, Japan.

出版信息

J Enzyme Inhib Med Chem. 2012 Aug;27(4):571-7. doi: 10.3109/14756366.2011.603129. Epub 2011 Oct 12.

DOI:10.3109/14756366.2011.603129
PMID:21992704
Abstract

Plasmin plays important roles in various physiological systems. The identification of inhibitors controlling its regulation represents a promising drug-discovery challenge. To develop selective inhibitors of plasmin, structural information of the binding modes is crucial. Here, a computational docking study was conducted to provide structural insight into plasmin subsite interactions with substrates/inhibitors. Predicted binding modes of two peptide-substrates (D/L-Ile-Phe-Lys), and potent and weak inhibitors (YO-2 and PKSI-527) suggested non-prime and prime subsite interactions relevant to recognition by plasmin. Predicted binding modes also correlated well with the experimental structure-activity relationships for plasmin substrates/inhibitors, namely the differences of K(M) values between the D- and L-peptide-substrates and inhibitory potencies of YO-2 and PKSI-527. In particular, interaction observed at a hydrophobic pocket near S2 and at a tunnel-shaped hydrophobic S1' was strongly suggested to be significantly involved in tight binding of inhibitors to plasmin. Our present findings may aid in the design of potent and selective plasmin inhibitors.

摘要

纤溶酶在各种生理系统中发挥着重要作用。鉴定控制其调节的抑制剂代表了一个有前途的药物发现挑战。为了开发纤溶酶的选择性抑制剂,了解其结合模式的结构信息至关重要。在这里,进行了计算对接研究,以提供有关纤溶酶亚基与底物/抑制剂相互作用的结构见解。两种肽底物(D/L-异亮氨酸-苯丙氨酸-赖氨酸)和有效和弱抑制剂(YO-2 和 PKSI-527)的预测结合模式表明,非主要和主要亚基相互作用与纤溶酶的识别有关。预测的结合模式也与纤溶酶底物/抑制剂的实验构效关系很好地相关,即 D-和 L-肽底物之间 K(M)值的差异以及 YO-2 和 PKSI-527 的抑制效力。特别是,在 S2 附近的疏水口袋和隧道形疏水 S1'处观察到的相互作用强烈表明其在抑制剂与纤溶酶的紧密结合中起着重要作用。我们目前的研究结果可能有助于设计有效的和选择性的纤溶酶抑制剂。

相似文献

1
Predicting subsite interactions of plasmin with substrates and inhibitors through computational docking analysis.通过计算对接分析预测纤溶酶与底物和抑制剂的亚位相互作用。
J Enzyme Inhib Med Chem. 2012 Aug;27(4):571-7. doi: 10.3109/14756366.2011.603129. Epub 2011 Oct 12.
2
Development of plasma kallikrein selective inhibitors.血浆激肽释放酶选择性抑制剂的研发。
Biopolymers. 1999;51(1):41-50. doi: 10.1002/(SICI)1097-0282(1999)51:1<41::AID-BIP5>3.0.CO;2-Y.
3
Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead.以腈为弹头的三肽类纤溶酶抑制剂的合成与评价。
J Pept Sci. 2012 Oct;18(10):620-5. doi: 10.1002/psc.2442. Epub 2012 Sep 7.
4
Inhibition of human leukocyte elastase, plasmin and matrix metalloproteinases by oleic acid and oleoyl-galardin derivative(s).油酸及其油酰基-半胱天冬酶抑制剂对人白细胞弹性蛋白酶、纤溶酶和基质金属蛋白酶的抑制作用。
Biochem Pharmacol. 2011 Mar 1;81(5):626-35. doi: 10.1016/j.bcp.2010.12.001. Epub 2010 Dec 10.
5
In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.基于三肽的α-酮杂环作为凝血酶抑制剂的深入研究。S1'亚位点的有效利用及其对基于结构的药物设计的意义。
J Med Chem. 2005 Mar 24;48(6):1984-2008. doi: 10.1021/jm0303857.
6
Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.丝氨酸蛋白酶纤溶酶的环状酮抑制剂的构效关系研究:设计、合成及生物活性
Bioorg Med Chem. 2006 Dec 15;14(24):8467-87. doi: 10.1016/j.bmc.2006.08.040. Epub 2006 Sep 12.
7
Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
Chem Pharm Bull (Tokyo). 1999 Aug;47(8):1141-4. doi: 10.1248/cpb.47.1141.
8
Design of plasma kallikrein inhibitors: functional and structural requirements of plasma kallikrein inhibitors.
Chem Pharm Bull (Tokyo). 1998 Mar;46(3):452-7. doi: 10.1248/cpb.46.452.
9
Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors.选择性含硼凝血酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 1999 Jul;7(7):1295-307. doi: 10.1016/s0968-0896(99)00069-3.
10
Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.采用基于配体和基于结构的联合方法,剖析代表性因子 Xa 和凝血酶抑制剂的选择性结构决定因素。
J Chem Inf Model. 2011 Aug 22;51(8):1966-85. doi: 10.1021/ci200185q. Epub 2011 Aug 1.

引用本文的文献

1
Prediction of substrates for glutathione transferases by covalent docking.通过共价对接预测谷胱甘肽转移酶的底物
J Chem Inf Model. 2014 Jun 23;54(6):1687-99. doi: 10.1021/ci5001554. Epub 2014 May 16.